S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
NASDAQ:ENTL

(ENTL) (ENTL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$24.00
$24.00
50-Day Range
$24.00
$24.06
52-Week Range
$11.47
$25.58
Volume
N/A
Average Volume
178,331 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ENTL stock logo

About (ENTL) Stock (NASDAQ:ENTL)

Entellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company's XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.

ENTL Stock News Headlines

Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Lask entlässt Trainer Sageder
Halle entlässt Ristic - Nachfolger fix
See More Headlines
Receive ENTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ENTL) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2016
Today
4/18/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ENTL
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Robert S. White
    President, Chief Executive Officer, Director
  • Brent A. Moen
    Chief Financial Officer, Corporate Secretary
  • Michael H. Rosenthal
    Chief Operating Officer
  • Jonelle R. Burnham
    Chief Compliance Officer, Vice President, General Counsel
  • Stephen R. Paidosh
    Vice President, Operations
  • Thomas D. Williamson
    Vice President - Sales
  • Kevin L. Mensink
    Vice President of Marketing
  • Martha J. Christian
    Vice President, Reimbursement
  • Timothy B. Petrick
    Vice President, Research and Development
  • Brian E. Farley
    Non-Executive Chairman of the Board

ENTL Stock Analysis - Frequently Asked Questions

How were (ENTL)'s earnings last quarter?

(ENTL) (NASDAQ:ENTL) issued its earnings results on Thursday, November, 3rd. The medical technology company reported ($0.50) EPS for the quarter, missing analysts' consensus estimates of ($0.37) by $0.13. The medical technology company had revenue of $17.90 million for the quarter, compared to the consensus estimate of $17.93 million. (ENTL)'s revenue for the quarter was up 20.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.32) earnings per share.

What other stocks do shareholders of (ENTL) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (ENTL) investors own include Intersect ENT (XENT), (RLYP) (RLYP), Twitter (TWTR), ACADIA Pharmaceuticals (ACAD), AcelRx Pharmaceuticals (ACRX), Aimmune Therapeutics (AIMT), Broadcom (AVGO), Aircastle (AYR) and Alibaba Group (BABA).

When did (ENTL) IPO?

(ENTL) (ENTL) raised $70 million in an IPO on Friday, January 30th 2015. The company issued 4,400,000 shares at $15.00-$17.00 per share. BofA Merrill Lynch and Piper Jaffray served as the underwriters for the IPO and William Blair and Canaccord Genuity were co-managers.

This page (NASDAQ:ENTL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners